In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 93, Issue 11, Pages 1232-1240
Publisher
Springer Nature
Online
2013-09-09
DOI
10.1038/labinvest.2013.107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A “Twist box” Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation
- (2012) Sara Piccinin et al. CANCER CELL
- Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
- (2012) Kristiaan Lenos et al. CANCER RESEARCH
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
- (2011) Hege O Ohnstad et al. BMC CANCER
- Functions of MDMX in the Modulation of the p53-Response
- (2011) Kristiaan Lenos et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Liposarcomas With Mixed Well-differentiated and Pleomorphic Features: A Clinicopathologic Study of 12 Cases
- (2010) Jennifer M. Boland et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Dedifferentiated Liposarcoma With “Homologous” Lipoblastic (Pleomorphic Liposarcoma-like) Differentiation: Clinicopathologic and Molecular Analysis of a Series Suggesting Revised Diagnostic Criteria
- (2010) Adrián Mariño-Enríquez et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis
- (2010) M. Ito et al. CLINICAL CANCER RESEARCH
- HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
- (2010) Mei Liang et al. MODERN PATHOLOGY
- The C terminus of p53 binds the N-terminal domain of MDM2
- (2010) Masha V Poyurovsky et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MDM4 (MDMX) and its Transcript Variants
- (2009) F. Mancini et al. CURRENT GENOMICS
- Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma
- (2009) Andrew E Horvai et al. MODERN PATHOLOGY
- Targeted Therapies: The Rare Cancer Paradigm
- (2009) Marco A. Pierotti et al. Molecular Oncology
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- MDM2-SNP 309 allele status does not affect sensitivity to MDM2 inhibitors in CLL
- (2008) S. N. Malek BLOOD
- SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a
- (2008) I. Seyfried et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started